Estudio de caso, paciente en hemodiálisis, antecedentes heredofamiliares con el modelo de Virginia Henderson / Case study, hemodialysis patient, family history with the Virginia Henderson model

El siguiente estudio de caso se realizó en una persona con enfermedad renal crónica secundaria a diabetes mellitus tipo 1 en tratamiento de hemodiálisis desde hace 7 años, se realizó con el fin llevar acabo las acciones e intervenciones encaminadas a contribuir en los cuidados de rehabilitación, así como aminorar las complicaciones de esta enfermedad para que la persona logre su independencia. La metodología está basada en el modelo de Virginia Henderson donde se encontraron necesidades de nutrición e hidratación, eliminación, evitar peligros y aprendizaje alterados, posteriormente se realiza los diagnósticos de enfermería y la planificación del cuidado mediante la taxonomía Nanda, Noc y Nic. Para esto se requisita la NOM-012-SSA3. 2012, mediante el cual se obtiene el consentimiento informado de la persona para ejecutar el plan de cuidados con los criterios que establece la norma para ejecutar las intervenciones con el fin de investigación para la salud, se realizó visita domiciliaria para una evaluación del plan de cuidados donde se concluye que en relación con la implicación familiar se logró cierto grado de independencia en el paciente, observando cambios positivos, conocimiento de la enfermedad y un mejor apego a su alimentación.

The following case study was carried out in a person with chronic kidney disease secondary to type 1 diabetes mellitus on hemodialysis treatment for 7 years, it was carried out in order to carry out actions and interventions aimed at contributing to rehabilitation care, as well how to reduce the complications of this disease so that the person can achieve independence. The methodology is based on the Virginia Henderson Model where needs for nutrition and hydration, elimination, danger avoidance and altered learning were found, subsequently nursing diagnoses and care planning are carried out using the Nanda, Noc and Nic taxonomy. For this, the NOM-012-SSA3 is required. 2012, through which the informed consent of the person is obtained to execute the care plan with the criteria established by the norm to execute the interventions for the purpose of health research, a home visit is made with which a evaluation of the care plan where it is concluded that in relation to family involvement, a certain degree of independence was achieved in the patient, positive changes were observed, a better knowledge of the disease, better adherence to their diet.

Hypocalcemia and bone mineral density changes following denosumab treatment in end-stage renal disease patients: a meta-analysis of observational studies.

The incidence of hypocalcemia and bone mineral density (BMD) changes in end-stage renal disease (ESRD) patients on denosumab remains unclear. We performed this meta-analysis to assess the incidence of denosumab-associated hypocalcemia and effects of denosumab on BMD in ESRD patients. A literature search was conducted using MEDLINE, EMBASE, and Cochrane Database from inception through November 2017 to identify studies evaluating incidence of denosumab-associated hypocalcemia and changes in serum calcium, phosphate, alkaline phosphatase (ALP), parathyroid hormone (PTH), and BMD from baseline to post-treatment course of denosumab in ESRD patients. Study results were pooled and analyzed using a random-effect model. The protocol for this meta-analysis is registered with PROSPERO (International Prospective Register of Systematic Reviews; no. CRD42017081074). Six observational studies with a total of 84 ESRD patients were enrolled. The pooled estimated incidence of hypocalcemia during denosumab treatment was 42% (95% CI 29-55%, I2 = 0%). Hypocalcemia occurred approximately 7 to 20 days after the first dose and reached nadir of low calcium levels in the first 2 weeks up to 2 months. However, there were no significant changes in serum calcium or phosphate from baseline to post-treatment course (≥ 3 months after treatment) with mean differences [MDs] of 0.20 mg/dL (95% CI, - 0.30 to 0.69 mg/dL) and - 0.10 mg/dL (95% CI, - 0.70 to 0.49 mg/dL). There were significant reductions in ALP and PTH levels with standardized mean differences (SMDs) of - 0.65 (95% CI - 1.13 to - 0.16) and - 1.89 (95% CI - 3.44 to - 0.34), respectively. There were significant increases in T-scores with MDs of 0.39 (95% CI 0.10 to 0.69) and 0.79 (95% CI 0.60 to 0.98) for lumbar spine and femoral neck, respectively. Our study demonstrates the estimated incidence of denosumab-associated hypocalcemia in dialysis patients of 42%. From baseline to post-treatment course, although there are no differences in serum calcium and phosphate, our findings suggest significant reductions in ALP and PTH and a significant increase in BMD. Currently, denosumab should not be considered as the treatment of choice in ESRD patients until more safety and efficacy data are available.

Lower kidney allograft survival in African-Americans compared to Hispanic-Americans with lupus.

Background and objective African-Americans and Hispanic-Americans with lupus are the two most common minority groups who receive kidney transplants in the USA. It is unknown if African-Americans and Hispanic-Americans with lupus have similar outcomes after kidney transplantation. In this study, we assessed whether African-Americans compared to Hispanic-Americans have worse kidney allograft survival after risk factors of rejection and other prognostic factors were matched between both groups. Methods Out of 1816 African-Americans and 901 Hispanic-Americans with lupus, who received kidney transplants between 1987 and 2006 and had complete records in the UNOS program, 478 pairs were matched in 16 baseline predictors and follow-up time employing a predicted probability of group membership. The primary outcome was kidney allograft survival. Main secondary outcomes were rejection, allograft failure attributed to rejection, and mortality. Results Matched pairs were predominantly women (81%) with the mean age of 36 years. 96% were on dialysis before transplantation. 89% of recipients received kidneys from deceased donors and 15.5% from expanded criteria donors. 12% of recipients had zero HLA mismatch. African-Americans compared to Hispanic-Americans had lower cumulative allograft survival during 12-year follow-up ( p < 0.001). African-Americans compared to Hispanic-Americans had higher rates of rejection (10.4 vs 6.73 events/100 patients-years; p = 0.0002) and allograft failure attributed to rejection (6.31 vs 3.99; p = 0.0023). However, African-Americans and Hispanic-Americans had similar mortality rates (2.71 vs 2.31; p = 0.4269). Conclusions African-Americans compared to Hispanic-Americans with lupus had lower kidney allograft survival when recognized risk factors of rejection were matched between groups.

Lupus vasculopathy: Diagnostic, pathogenetic and therapeutic considerations.

A rare form of vascular disease in systemic lupus erythematosus (SLE), lupus vasculopathy is characterized by necrosis and accumulation of immunoglobulins (IGs) and complements in the wall of arterioles and small arteries resulting in luminal narrowing. Lupus vasculopathy often accompanies lupus nephritis and portends a poor prognosis. Although there is general agreement on the treatment of lupus nephritis, effective treatment strategies for lupus vasculopathy remain to be defined. We report a 20-year-old woman with SLE who presented with generalized tonic-clonic seizure. Her immunosuppressive regimen consisted of mycophenolate mofetil, prednisone and hydroxychloroquine. On physical examination, she was Cushingoid in appearance and hypertensive. Laboratory tests indicated renal disease. Coagulation studies disclosed de novo lupus anticoagulant. Magnetic resonance imaging of the brain demonstrated acute focal cerebral hemorrhage. Echocardiography revealed reduced ejection fraction and severe mitral regurgitation. Despite high-dose glucocorticoids and mycophenolate mofetil, renal function remained poor. Kidney biopsy demonstrated lupus vasculopathy and glomerulonephritis. Plasma exchange therapy and intravenous cyclophosphamide were administered. Over the ensuing four weeks, renal function improved, complement levels increased, autoantibody titers decreased and lupus anticoagulant disappeared. In conclusion, lupus vasculopathy can occur in SLE despite a heavy immunosuppressive regimen. Antiphospholipid antibodies might be involved in the pathogenesis of lupus vasculopathy. Plasma exchange therapy in conjunction with intravenous cyclophosphamide may represent an effective treatment strategy for lupus vasculopathy.

Kidney allograft survival of African American and Caucasian American recipients with lupus.

BACKGROUND: African Americans with lupus who receive kidney transplants have high prevalence of predictors of allograft failure, which can explain their poor outcomes. METHODS: Of 1223 African Americans and 1029 Caucasian Americans with lupus who received kidney transplants from deceased donors between 1987 and 2006 with complete records in the UNOS program, 741 pairs were matched in 16 predictors employing a predicted probability of group membership. The primary outcome was allograft failure. Main secondary outcomes were rejection, allograft failure due to rejection, and mortality. RESULTS: Matched pairs were predominantly women (82%) with a mean age of 39 years. Twenty-four percent of recipients received kidneys from expanded criteria donors. African Americans and Caucasian Americans matched well (p ≥ 0.05): donor age, gender and race; recipient age, gender, education and insurance; dialysis prior to transplant, kidneys from expanded criteria donors, cold ischemia time, history of prior kidney transplant, panel reactive antibodies, human leukocyte antigens mismatch, blood type compatibility, transplant Era, and follow-up time. Contrary to the unmatched cohort with significantly higher allograft failure rate (events per 100 patient-years) in African Americans compared to Caucasian Americans (10.49 vs 6.18, p<0.001), matched pairs had similar allograft failure rates (8.41 vs 7.81, p=0.418). Matched pairs also had similar rates of rejections (9.82 vs 9.39, p=0.602), allograft failure due to rejection (6.19 vs 5.71, p=0.453), and mortality (2.79 vs 3.52, p=0.097). CONCLUSION: In lupus recipients of kidney transplants from deceased donors, African American and Caucasian Americans have similar allograft failure rates when predictors are matched between groups.

Bond Fukui functions as descriptor of the electron density reorganization in π conjugated systems.

The bond Fukui function is introduced and tested as a new reactivity index capable of predicting the evolution of bond breaking and formation processes during an organic reaction involving π conjugated systems. As an illustration, we examine many cases where substituted ethylenes and dienes may respond to different reagents to yield cycloaddition, Michael addition, and other reactions at double bonds.

Isolation by distance among California sea lion populations in Mexico: redefining management stocks.

Understanding the spatial structure of a population is critical for effective assessment and management. However, direct observation of spatial dynamics is generally difficult, particularly for marine mammals. California sea lions (Zalophus californianus) are polygynous pinnipeds distributed along the Pacific coast of North America. The species' range has been subdivided into three management stocks based on differences in mitochondrial DNA, but to date no studies have considered nuclear genetic variation, and thus we lack a comprehensive understanding of gene flow patterns among sea lion colonies. In light of recent population declines in the Gulf of California, Mexico, it is important to understand spatial structure to determine if declining sea lion colonies are genetically isolated from others. To define population subdivision and identify sex biases in gene flow, we analysed a 355-bp sequence of the mitochondrial DNA control region and 10 polymorphic microsatellite loci from 355 tissue samples collected from six colonies distributed along Mexican waters. Using a novel approach to estimate sex biases in gene flow, we found that male sea lions disperse on average 6.75 times more frequently than females. Analyses of population subdivision strongly suggest a pattern of isolation by distance among colonies and challenge current stock definitions. Based on these results, we propose an alternative classification that identifies three Mexican management units: Upper Gulf of California, Southern Baja Peninsula, and Upper Pacific Coast of Baja. This revised classification should be considered in future assessment and management of California sea lion populations in Mexican waters.

[Intervention strategies for the rational use of anti-microbials]. / Estrategias de intervención para el uso racional de antimicrobianos.

OBJECTIVE: To evaluate the impact of two strategies aimed at improving the prescription of antibiotics in the primary care context. DESIGN: Experimental crossed-intervention study, with control group and randomised allocation to groups. SETTING: Two primary care helth districts (Camas and Sierra Norte). PARTICIPANTS: 84 general practitioners for whom computerised prescription data were available, and who worked for over 40% of the working days of the study period. Interventions. In the intervention group, training sessions were conducted and written information was sent out. In the control group, only written information was sent. MAIN MEASUREMENTS: The impact of the interventions was evaluated through the student´s t test for paired data. Variables were the DHD of antibiotics, selection of first-level antibiotics and %RSP of antibiotics out of total pharmaceutical cost. Secondary measurements included duration of the effect of the intervention and description of the group who responded. RESULTS: In the intervention group, the DHD dropped significantly (from 17.4±1.4 to 12.2±0.9) (P<.05), as did the %RSP (from 6.96%±0.6 to 5.19%±0.8), as against the control group. The impact of the intervention lasted 1.5 years, when information was sent at one year from the intervention. The profile of the doctors who responded to the intervention was women aged 46 with MIR (residential) training. CONCLUSIONS: To modify antibiotic prescription habits, training sessions accompanied by written information gives good lasting results. The profiles of respondents/non-respondents depended on sex, age and training.